Fulcrum Therapeutics, INC. (FULC) — DEF 14A Filings
All DEF 14A filings from Fulcrum Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Fulcrum Therapeutics Executive Compensation Details
— Apr 30, 2025 Risk: low
Fulcrum Therapeutics, Inc. filed a DEF 14A on April 30, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes -
Fulcrum Therapeutics Announces 2024 Annual Meeting of Stockholders on June 17
— Apr 19, 2024 Risk: low
Fulcrum Therapeutics, Inc. (FULC) filed a Proxy Statement (DEF 14A) with the SEC on April 19, 2024. Fulcrum Therapeutics will hold its 2024 Annual Meeting of St
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX